Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 302.00
Bid: 301.50
Ask: 305.00
Change: -14.00 (-4.43%)
Spread: 3.50 (1.161%)
Open: 315.50
High: 315.50
Low: 302.00
Prev. Close: 316.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

6 Nov 2015 07:00

RNS Number : 7178E
Synthomer PLC
06 November 2015
 

November 6th 2015

Synthomer plc

Q3 Trading Update

Continued progress, in line with full year expectations

Synthomer plc ('Synthomer' or 'the Group') today issues a trading update for the third quarter ended September 30th, 2015.

Trading

Europe and North America

The Europe and North America segment has continued to perform in line with the positive trends seen during the first half of the year. Whilst volumes were lower than Q3 2014 due to ongoing weakness in our Paper business, we continued to make good progress driven by a further improvement in Construction and Coatings and Functional Polymers. The recent falls in raw material prices helped to deliver a modest improvement in unit margins in Q3 over Q2 and the comparable period in 2014.

Asia and Rest of World

The Asia and Rest of World segment has continued to perform strongly in Q3, with both volumes and unit margins higher than in Q2 and Q3 2014. This ongoing momentum reflects a further rise in volumes and unit margins in our Nitrile business. Our principal revenue streams and raw material costs in Asia are US dollar denominated, and accordingly the recent volatility in the Malaysian Ringgit has a limited impact on the reported operating profit in Sterling.

Financial Position

Group debt increased from £77.2m to £94.8m following the Final Ordinary and Special dividend payments of £42.8m on 3 July 2015, offset by continued strong cash generation of £26.0m during the period.

The Group balance sheet remains strong with the net debt/ EBITDA ratio below 1x.

Outlook

Overall, the Board's expectations for Full Year 2015 remain unchanged.

Looking further ahead, in Europe and North America, our strategy continues to focus on innovation, margin improvement and tight cost control to drive performance. Consequently, we expect this segment to continue at similar volumes and margins through 2016.

As stated in our interim results, a number of Asian Nitrile producers, including Synthomer, have announced plans to increase capacity during the latter part of 2016 and early 2017. Whilst we are confident of continued growth in the market and strong demand going into next year, we expect this planned capacity increase to impact the supply/ demand balance during the second half of 2016 leading to similar net volumes and margins to 2015 for the year as a whole. 

-ENDS-

ENQUIRIES:

Calum MacLean, Chief Executive Officer

Charles Armitstead

Stephen Bennett, Chief Financial Officer

Pendomer Communications

Tel: + 44 1279 436211

Tel: + 44 20 3603 5220

 

The Company will hold a conference call for investors and analysts at 0800 BST today. 

Please dial + 44 20 3426 2890 to gain access to the call.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBABTTMBIMBBA
Date   Source Headline
5th Aug 20217:01 amRNSBoard Update
5th Aug 20217:00 amRNSInterim Results
20th Jul 202112:05 pmRNSSynthomer plc receives Green Economy Mark
19th Jul 20217:00 amRNSTrading Update
14th Jul 202111:02 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSAppointment of Non-Executive Director
6th Jul 202112:37 pmRNSDirector/PDMR Shareholding
25th Jun 202110:01 amRNSFurther re Appointment of Group CEO
23rd Jun 20217:00 amRNSAppointment of Group Chief Executive Officer
18th May 20213:53 pmRNSDirector Declaration
12th May 20212:56 pmRNSDirector Declaration
6th May 20214:17 pmRNSDirector Declaration
6th May 20213:15 pmRNSDirector/PDMR Shareholding
29th Apr 20214:01 pmRNSResult of AGM
21st Apr 20217:00 amRNSQ1 Trading Update
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:56 amRNSAnnual Financial Report
19th Mar 20212:38 pmRNSDirector/PDMR Shareholding
12th Mar 20213:17 pmRNSDirector/PDMR Shareholding
12th Mar 20213:16 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
11th Mar 20219:43 amRNSHolding(s) in Company
4th Mar 202112:43 pmRNSPreliminary results – correction
4th Mar 20217:00 amRNSPreliminary Results year ended 31 December 2020
1st Mar 202112:58 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSStatement RE: Press Speculation
22nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:38 pmRNSHolding(s) in Company
14th Jan 20217:00 amRNSPre-Close Trading Update and Board Update
12th Jan 20219:36 amRNSHolding(s) in Company
6th Jan 20219:10 amRNSDirector Declaration
4th Jan 202110:09 amRNSDirector Declaration
23rd Dec 20204:54 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSAppointment of New Chair
18th Nov 20207:00 amRNSInvestor Seminar
17th Nov 20201:34 pmRNSDirector/PDMR Shareholding
16th Oct 202010:33 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSQ3 Trading Update
7th Oct 20209:20 amRNSHolding(s) in Company
4th Sep 20203:15 pmRNSDirector Declaration
6th Aug 20207:00 amRNSInterim Results for six months ended 30 June 2020
27th Jul 202010:00 amRNSPost Stabilisation Notice
16th Jul 20207:00 amRNSAppointment of Non-Executive Director
8th Jul 20204:16 pmRNSHolding(s) in Company
8th Jul 20204:14 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSSynthomer announces the pricing of senior notes
16th Jun 202011:54 amRNSPre Stabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.